Back to Search Start Over

Multiple sclerosis in Somali Americans: Nature or nurture?

Authors :
Nathoo, Nabeela
Neyal, Nur
Atkinson, Elizabeth J.
Weinshenker, Brian G.
Tillema, Jan-Mendelt
Keegan, B.Mark
Pittock, Sean J.
Tobin, W.Oliver
Flanagan, Eoin P.
Gavrilova, Ralitza
Toledano, Michel
Young, Nathan
Truitt, Karen
Okuda, Darin T.
Zeydan, Burcu
Kantarci, Orhun H.
Source :
Multiple Sclerosis & Related Disorders; Oct2024, Vol. 90, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

• Most Somali Americans with multiple sclerosis moved to the USA post-puberty. • Somali Americans are younger at multiple sclerosis onset than African Americans. • Somali Americans enter progressive MS at an older age than African Americans. • Somali Americans have similar multiple sclerosis disease course to White Americans. Differences in the MS course between White and Black populations is well accepted. The existence of a large Somali immigrant population in Minnesota facilitates a study of MS characteristics in this immigrant native African population. The objective of this study was to compare Somali American (SA), African American (AA), and White American (WA) persons with MS (pwMS) regarding clinical features and disease modifying therapy (DMT) use. This single center (Mayo Clinic) geographically-restricted retrospective cohort study (residing within 250 miles of Rochester, MN, USA) included participants seen before May 2023. Age at immigration to the USA; age at MS onset; DMT use/type; MS phase/phenotype; age at progressive MS (PMS) onset; and proportion with severe MS (expanded disability status scale-EDSS ≥6) were examined. 18 SApwMS, 92 AApwMS, and 94 WApwMS were included. Of the 15 SApwMS not born in USA, 3/15 immigrated pre-puberty, 3/15 peri‑puberty, 8/15 post-puberty, and 1/15 at an unknown date. SApwMS were younger at MS onset (median years, interquartile range (IQR)=25, 22–33 vs. AApwMS: 31, 25–38; p = 0.049 vs. WApwMS: 35, 27–41; p = 0.022). DMT use frequencies were 13/19 SApwMS, 69/92 AApwMS, 80/94 WApwMS (p > 0.05). SApwMS were treated with DMT earlier than AApwMS (HR 2.16, p = 0.012) and WApwMS (HR 1.86, p = 0.041). SApwMS were less commonly treated with natalizumab (SApwMS 0 %, AApwMS 13 %, WApwMS 25 %; p = 0.035) and anti-CD20 therapies (SApwMS 23 %, AApwMS 23 %, WApwMS 48 %; p = 0.005). PMS occurred in 3/19 SApwMS, 28/92 AApwMS and 29/94 WApwMS (p > 0.05). Age of PMS onset in SApwMS (47 years, 34–57) was similar to WApwMS (47 years, 31–71; p > 0.05) but older than AApwMS (41 years, 18–7; p = 0.008). SApwMS that recently immigrated to the USA have similar disease course to WApwMS, and better than AApwMS from the same geographical region. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22110348
Volume :
90
Database :
Supplemental Index
Journal :
Multiple Sclerosis & Related Disorders
Publication Type :
Academic Journal
Accession number :
179556853
Full Text :
https://doi.org/10.1016/j.msard.2024.105842